Abbott closes $250m Topera buyout

Abbott says it closed the $250 million buyout of Topera Medical and its cardiac arrhythmia mapping technology.

Abbott (NYSE:ABT) said yesterday that it closed its acquisition of Topera Medical, paying $250 million up front and placing another unspecified amount on the table in performance-based milestones.

Topera Medical, Abbott Laboratories

News Well, Cardiac Rhythm Management, Mergers & Acquisitions

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xHNCb1